DOCS - Doximity downgraded at J.P. Morgan on valuation and advertising concerns
2025-10-10 11:08:59 ET
More on Doximity
- Doximity: Valuation Is Too Expensive For My Liking
- Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
- Doximity: Slowing Sales And EBITDA Growth
- Doximity, LivaNova downgraded as Goldman Sachs reviews MedTech and Health IT coverage
- Doximity rises on Q1 beat; buys Canadian AI-based clinical reference firm